586 related articles for article (PubMed ID: 16869817)
1. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance.
Anderson BJ; Allegaert K; Van den Anker JN; Cossey V; Holford NH
Br J Clin Pharmacol; 2007 Jan; 63(1):75-84. PubMed ID: 16869817
[TBL] [Abstract][Full Text] [Related]
2. Limited predictability of amikacin clearance in extreme premature neonates at birth.
Allegaert K; Anderson BJ; Cossey V; Holford NH
Br J Clin Pharmacol; 2006 Jan; 61(1):39-48. PubMed ID: 16390350
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants.
Chen Y; Wu D; Dong M; Zhu Y; Lu J; Li X; Chen C; Li Z
Eur J Clin Pharmacol; 2018 Jul; 74(7):921-930. PubMed ID: 29602981
[TBL] [Abstract][Full Text] [Related]
4. Renal drug clearance in preterm neonates: relation to prenatal growth.
Allegaert K; Anderson BJ; van den Anker JN; Vanhaesebrouck S; de Zegher F
Ther Drug Monit; 2007 Jun; 29(3):284-91. PubMed ID: 17529884
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline.
Marqués-Miñana MR; Saadeddin A; Peris JE
Br J Clin Pharmacol; 2010 Nov; 70(5):713-20. PubMed ID: 21039765
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
Mehrotra N; Tang L; Phelps SJ; Meibohm B
Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
[TBL] [Abstract][Full Text] [Related]
7. Inter-individual variability in propofol pharmacokinetics in preterm and term neonates.
Allegaert K; Peeters MY; Verbesselt R; Tibboel D; Naulaers G; de Hoon JN; Knibbe CA
Br J Anaesth; 2007 Dec; 99(6):864-70. PubMed ID: 17965417
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of vancomycin in premature Malaysian neonates: identification of predictors for dosing determination.
Lo YL; van Hasselt JG; Heng SC; Lim CT; Lee TC; Charles BG
Antimicrob Agents Chemother; 2010 Jun; 54(6):2626-32. PubMed ID: 20385872
[TBL] [Abstract][Full Text] [Related]
9. Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study.
Nielsen EI; Sandström M; Honoré PH; Ewald U; Friberg LE
Clin Pharmacokinet; 2009; 48(4):253-63. PubMed ID: 19492870
[TBL] [Abstract][Full Text] [Related]
10. Renal Function Descriptors in Neonates: Which Creatinine-Based Formula Best Describes Vancomycin Clearance?
Bhongsatiern J; Stockmann C; Yu T; Constance JE; Moorthy G; Spigarelli MG; Desai PB; Sherwin CM
J Clin Pharmacol; 2016 May; 56(5):528-40. PubMed ID: 26412385
[TBL] [Abstract][Full Text] [Related]
11. Covariates of tramadol disposition in the first months of life.
Allegaert K; van den Anker JN; de Hoon JN; van Schaik RH; Debeer A; Tibboel D; Naulaers G; Anderson BJ
Br J Anaesth; 2008 Apr; 100(4):525-32. PubMed ID: 18303070
[TBL] [Abstract][Full Text] [Related]
12. Maturation of the glomerular filtration rate in neonates, as reflected by amikacin clearance.
De Cock RF; Allegaert K; Schreuder MF; Sherwin CM; de Hoog M; van den Anker JN; Danhof M; Knibbe CA
Clin Pharmacokinet; 2012 Feb; 51(2):105-17. PubMed ID: 22229883
[TBL] [Abstract][Full Text] [Related]
13. Impact of ibuprofen administration on renal drug clearance in the first weeks of life.
Allegaert K; Rayyan M; Anderson BJ
Methods Find Exp Clin Pharmacol; 2006 Oct; 28(8):519-22. PubMed ID: 17136231
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates.
Mulubwa M; Griesel HA; Mugabo P; Dippenaar R; van Wyk L
Drugs R D; 2020 Jun; 20(2):105-113. PubMed ID: 32266599
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics and dose optimization of vancomycin in neonates.
Lee SM; Yang S; Kang S; Chang MJ
Sci Rep; 2021 Mar; 11(1):6168. PubMed ID: 33731764
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Vancomycin Use in Late-Onset Neonatal Sepsis Using the Area Under the Concentration-Time Curve to the Minimum Inhibitory Concentration ≥400 Target.
Bhongsatiern J; Stockmann C; Roberts JK; Yu T; Korgenski KE; Spigarelli MG; Desai PB; Sherwin CM
Ther Drug Monit; 2015 Dec; 37(6):756-65. PubMed ID: 26562817
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of vancomycin in neonates.
Seay RE; Brundage RC; Jensen PD; Schilling CG; Edgren BE
Clin Pharmacol Ther; 1994 Aug; 56(2):169-75. PubMed ID: 8062493
[TBL] [Abstract][Full Text] [Related]
18. Time-Varying Clearance in Milrinone Pharmacokinetics from Premature Neonates to Adolescents.
O'Hanlon CJ; Sumpter A; Anderson BJ; Hannam JA
Clin Pharmacokinet; 2024 May; 63(5):695-706. PubMed ID: 38613610
[TBL] [Abstract][Full Text] [Related]
19. Age and size are the major covariates for prediction of levobupivacaine clearance in children.
Chalkiadis GA; Anderson BJ
Paediatr Anaesth; 2006 Mar; 16(3):275-82. PubMed ID: 16490091
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenation.
Mulla H; Pooboni S
Br J Clin Pharmacol; 2005 Sep; 60(3):265-75. PubMed ID: 16120065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
